TLR9 and glioblastoma: Taken together, the described data suggest that the increased tissue expression level of the majority of PGRN-related receptors (SORT1, TNFR1, EPHA2 and TLR9) is strongly correlated with the aggressive capacity of GBM and poor prognoses for these patients.